OXIDATION PHENOTYPE - COMPARISON BETWEEN DEBRISOQUINE AND DEXTROMETHORPHAN TESTS

被引：0
|
作者：
VINCENTVIRY, M [1 ]
RICHE, I [1 ]
SIEST, G [1 ]
GALTEAU, MM [1 ]
机构：
[1] LAB CTR MED PREVENT,F-54500 VANDOEUVRE NANCY,FRANCE
来源：
CLINICAL CHEMISTRY | 1989年 / 35卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1184 / 1185
页数：2
相关论文
共 50 条
  • [1] EQUIVALENCE OF DEBRISOQUINE AND DEXTROMETHORPHAN TESTS FOR DETERMINING OXIDATION PHENOTYPE
    ROZENEK, S
    VINCENTVIRY, M
    MULLER, J
    GALTEAU, MM
    SIEST, G
    ANNALES DE BIOLOGIE CLINIQUE, 1988, 46 (07) : 534 - 534
  • [2] CAFFEINE TESTS, DEBRISOQUINE TESTS AND DEXTROMETHORPHAN TESTS USING PRESERVED URINE
    VINCENTVIRY, M
    RICHE, I
    RALLET, A
    GALTEAU, MM
    SIEST, G
    ANNALES DE BIOLOGIE CLINIQUE, 1988, 46 (07) : 571 - 571
  • [3] THE RELATIONSHIP BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND THE PHARMACOKINETICS OF CHLORPROPAMIDE
    KALLIO, J
    HUUPPONEN, R
    PYYKKO, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (01) : 93 - 95
  • [4] THE RELATIONSHIP BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND THE PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPRANOLOL
    LENNARD, MS
    JACKSON, PR
    FREESTONE, S
    TUCKER, GT
    RAMSAY, LE
    WOODS, HF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (06) : 679 - 685
  • [5] LACK OF RELATIONSHIP BETWEEN TOLBUTAMIDE METABOLISM AND DEBRISOQUINE OXIDATION PHENOTYPE
    PEART, GF
    BOUTAGY, J
    SHENFIELD, GM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 33 (04) : 397 - 402
  • [6] LACK OF RELATIONSHIP BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND THE KINETICS OF TOLBUTAMIDE
    SHENFIELD, GM
    BOUTAGY, J
    PEART, GFD
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 116 - 116
  • [7] LACK OF RELATIONSHIP BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND THE PHARMACOKINETICS OF QUININE
    WANWIMOLRUK, S
    CHALCROFT, S
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (05) : 617 - 620
  • [8] Relationship between debrisoquine oxidation phenotype and susceptibility to lung cancer
    Sardas, S
    Cok, I
    TOXICOLOGY, 2001, 164 (1-3) : 153 - 153
  • [9] DEBRISOQUINE OXIDATION PHENOTYPE IN A SPANISH POPULATION
    BENITEZ, J
    COBALEDA, J
    LOZANO, L
    ELENA, A
    CERMENO, JA
    MARIN, J
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 216 - 216
  • [10] IS THERE A LINK BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND LUNG-CANCER SUSCEPTIBILITY
    HORSMANS, Y
    DESAGER, JP
    HARVENGT, C
    BIOMEDICINE & PHARMACOTHERAPY, 1991, 45 (08) : 359 - 362
12345